

Mosapride Market Scope: Industry Analysis, Market
Size, Growth, Trends Till 2031
Request Sample Report
Mosapride market research indicates robust growth driven by increasing gastrointestinal disorders and rising awareness of gut health. The global market size is estimated to reach approximately USD 500 million by 2025, with a compound annual growth rate (CAGR) of 7%. Emerging markets and innovations in formulations are key growth drivers. Request Sample Report
◍ Sumitomo Dainippon Pharma
◍ Konghong Pharmaceutical
◍ Dainippon Pharmaceutical Co., Ltd.
◍ Nihon Generic
◍ NIPPON CHEMIPHAR CO., LTD.
◍ Lunan Pharmaceutical Group
◍ HAOSON PHARMA
◍ DAIICHI SANKYO
◍ SAWAI PHARMACEUTICAL CO., LTD.
The Mosapride market features key players like Sumitomo Dainippon Pharma and Dainippon Pharmaceutical, leveraging strategic partnerships and R&D to enhance drug development. Companies like HAOSON PHARMA and NIPPON CHEMIPHAR focus on production efficiency, driving market growth. Sales revenues of select firms include: Sumitomo Dainippon Pharma: $2 billion, DAIICHI SANKYO: $10 billion.
Gastritis
Dyspepsia
Others
Request Sample Report
Tablet
Capsule
Others
Request Sample Report
$ X Billion USD